| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10154282 | Transfusion Clinique et Biologique | 2018 | 5 Pages |
Abstract
Evolution of French HAS/ANSM guidelines in 2015 about optimal platelet transfusion dose for patients brought us to review about our practices for platelet concentrates delivery in EFS Grand-Est region. In addition, pathogen inactivation in platelet concentrates has been implemented all over the country and transfusion centers have merged. All these changes required harmonization. In this context, our major issue was to answer patient's requirements, according to the new guidelines keeping in mind the cost effectiveness on public finances. We report here on the changes in our practices and their impacts.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
D. Kientz, C. Humbrecht, H. Isola, C. Gachet,